REFERENCES
- Berenbaum F. COX-3: fact or fancy?. Jt. Bone Spine 2004; 71: 451–453
- Berg J. M., Tymoczko J. L., Stryer L. Biochemistry. W.H. Freeman, New York 2001
- Bessems J. G., Vermeulen N. P. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit. Rev. Toxicol. 2001; 31: 55–138, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Boréus L. O., Sandberg F. A comparison of some pharmacological effects of acetophenetidin and N-acetyl-p-aminophenol. Adv. Physiol. Scand. 1953; 28: 261–265, [CSA]
- Bromer M. Q., Black M. Acetaminophen hepatotoxicity. Clin. Liver Dis. 2003; 7: 351–367, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Büch H., Pfleger K., Rummel W., Ullrich V., Hey D., Staudinger H. Studies on the oxidative metabolism of phenacetin in rats (in German). Biochem. Pharmacol. 1967; 16: 2247–2256, [CROSSREF], [CSA]
- Calder I. C., Hart S. J., Healey K., Ham K. N. N-hydroxyacetaminophen: a postulated toxic metabolite of acetaminophen. J. Med. Chem. 1981; 24: 988–993, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chandrasekharan N. V., Dai H., Roos K. L., Evanson N. K., Tomsik J., Elton T. S., Simmons D. L. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 13926–13931, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chen W., Koenigs L. L., Thompson S. J., Peter R. M., Rettie A. E., Trager W. F., Nelson S. D. Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A. Chem. Res. Toxicol. 1998; 11: 295–301, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Coen M., Lenz E. M., Nicholson J. K., Wilson I. D., Pognan F., Lindon J. C. An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem. Res. Toxicol. 2003; 16: 295–303, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Coles B., Wilson I., Wardman P., Hinson J. A., Nelson S. D., Ketterer B. The spontaneous and enzymatic reaction of N-acetyl-p-benzoquinonimine with glutathione: a stopped-flow kinetic study. Arch. Biochem. Biophys. 1988; 264: 253–260, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Corcoran G. B., Mitchell J. R., Vaishnav Y. N., Horning E. C. Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine. Mol. Pharmacol. 1980; 18: 536–542, [PUBMED], [INFOTRIEVE], [CSA]
- Costa E., Karczmar A. G., Vesell E. S. Bernard B. Brodie and the rise of chemical pharmacology. Annu. Rev. Pharmacol. Toxicol. 1989; 29: 1–21, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Couzin J. Drug safety. FDA panel urges caution on many anti-inflammatory drugs. Science 2005; 307: 1183–1185, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Crofford L. J. COX-1 and COX-2 tissue expression: implications and predictions. J. Rheumatol. 1997; 24(Suppl. 49)15–19, [CSA]
- Dahlin D. C., Miwa G. T., Lu A. Y., Nelson S. D. N-Acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc. Natl. Acad. Sci. U. S. A. 1984; 81: 1327–1331, [PUBMED], [INFOTRIEVE], [CSA]
- de Morais S. M., Wells P. G. Enhanced acetaminophen toxicity in rats with bilirubin glucuronyl transferase deficiency. Hepatology 1989; 10: 163–167, [PUBMED], [INFOTRIEVE], [CSA]
- de Morais S. M., Chow S. Y., Wells P. G. Biotransformation and toxicity of acetaminophen in congenic RHA rats with or without a hereditary deficiency in bilirubin UDP-glucuronosyltransferase. Toxicol. Appl. Pharmacol. 1992a; 117: 81–87, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- de Morais S. M., Uetrecht J. P., Wells P. G. Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert’s syndrome. Gastroenterology 1992b; 102: 577–586, [PUBMED], [INFOTRIEVE], [CSA]
- Dinchuk J. E., Liu R. Q., Trzaskos J. M. COX-3: in the wrong frame in mind. Immunol. Lett. 2003; 86: 121, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dong H., Haining R. L., Thummel K. E., Rettie A. E., Nelson S. D. Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen. Drug Metab. Dispos. 2000; 28: 1397–1400, [PUBMED], [INFOTRIEVE], [CSA]
- Estabrook R. W. A tribute to James Robert Gillette. Drug Metab. Dispos. 2003; 31: 1459–1460, [CROSSREF], [CSA]
- Gaakeer H. A., De Ruiter H. J. Carcinoma of the renal pelvis following the abuse of phenacetin-containing analgesic drugs. Br. J. Urol. 1979; 51: 188–192, [PUBMED], [INFOTRIEVE], [CSA]
- Gemborys M. W., Gribble G. W., Mudge G. H. Synthesis of N-hydroxyacetaminophen, a postulated toxic metabolite of acetaminophen, and its phenolic sulfate conjugate. J. Med. Chem. 1978; 21: 649–652, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gyamlani G. G., Parikh C. R. Acetaminophen toxicity: suicidal vs. accidental. Crit. Care. 2002; 6: 155–159, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hazelton G. A., Hjelle J. J., Klaassen C. D. Effects of cysteine pro-drugs on acetaminophen-induced hepatotoxicity. J. Pharmacol. Exp. Ther. 1986; 237: 341–349, [PUBMED], [INFOTRIEVE], [CSA]
- Hinson J. A. Reactive metabolites of phenacetin and acetaminophen: a review. Environ. Health Perspect. 1983; 49: 71–79, [PUBMED], [INFOTRIEVE], [CSA]
- Hinson J. A., Pike S. L., Pumford N. R., Mayeux P. R. Nitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetaminophen in mice. Chem. Res. Toxicol. 1998; 11: 604–607, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hinson J. A., Reid A. B., McCullough S. S., James L. P. Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metab. Rev. 2004; 36: 805–822, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hoffmann K. J., Streeter A. J., Axworthy D. B., Baillie T. A. Identification of the major covalent adduct formed in vitro and in vivo between acetaminophen and mouse liver proteins. Mol. Pharmacol. 1985; 27: 566–573, [PUBMED], [INFOTRIEVE], [CSA]
- Holtzman J. L. The role of covalent binding to microsomal proteins in the hepatotoxicity of acetaminophen. Drug Metab. Rev. 1995; 27: 277–297, [PUBMED], [INFOTRIEVE], [CSA]
- Jaeschke H., Knight T. R., Bajt M. L. The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity. Toxicol. Lett. 2003; 144: 279–288, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- James L. P., Mayeux P. R., Hinson J. A. Acetaminophen-induced hepatotoxicity. Drug Metab. Dispos. 2003; 31: 1499–1506, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jollow D. J., Mitchell J. R., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Ther. 1973; 187: 195–202, [PUBMED], [INFOTRIEVE], [CSA]
- Kolb F. A., Zhang H., Jaronczyk K., Tahbaz N., Hobman T. C., Filipowicz W. Human dicer: purification, properties, and interaction with PAZ PIWI domain proteins. Methods Enzymol 2005; 392: 316–336, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Liu L., Klaassen C. D. Different mechanism of saturation of acetaminophen sulfate conjugation in mice and rats. Toxicol. Appl. Pharmacol. 1996; 139: 128–134, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mann C. C., Plummer M. L. The Aspirin Wars: Money, Medicine, and 100 Years of Rampant Competition. Knopf, New York 1991
- Martin C. N., Garner R. C. The identification and assessment of covalent binding in vitro and in vivo. Biochemical Toxicology: A Practical Approach, K. Snell, B. Mullock. IRL Press, Oxford 1987; 109–128
- Mason R. P., Fischer V. Free radicals of acetaminophen: their subsequent reactions and toxicological significance. Fed. Proc. 1986; 45: 2493–2499, [PUBMED], [INFOTRIEVE], [CSA]
- McClain C. J., Kromhout J. P., Peterson F. J., Holtzman J. L. Potentiation of acetaminophen hepatotoxicity by alcohol. JAMA 1980; 244: 251–253, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- McClain C. J., Price S., Barve S., Devalarja R., Shedlofsky S. Acetaminophen hepatotoxicity: an update. Curr. Gastroenterol. Rep. 1999; 1: 42–49, [PUBMED], [INFOTRIEVE], [CSA]
- McGirr L. G., Subrahmanyam V. V., Moore G. A., O’Brien P. J. Peroxidase-catalyzed-3-(glutathion-S-yl)-p, p′-biphenol formation. Chem. Biol. Interact. 1986; 60: 85–99, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- McJunkin B., Barwick K. W., Little W. C., Winfield J. B. Fatal massive hepatic necrosis following acetaminophen overdose. JAMA 1976; 236: 1874–1875, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- McMurray R. W., Hardy K. J. Cox-2 inhibitors: today and tomorrow. Am. J. Med. Sci. 2002; 323: 181–189, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mitchell J. R., Jollow D. J., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 1973a; 187: 185–194, [PUBMED], [INFOTRIEVE], [CSA]
- Mitchell J. R., Jollow D. J., Potter W. Z., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J. Pharmacol. Exp. Ther. 1973b; 187: 211–217, [PUBMED], [INFOTRIEVE], [CSA]
- Mitchell J. A., Akarasereenont P., Thiemermann C., Flower R. J., Vane J. R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 11693–11697, [PUBMED], [INFOTRIEVE], [CSA]
- Morris M. E., Levy G. Serum concentration and renal excretion by normal adults of inorganic sulfate after acetaminophen, ascorbic acid, or sodium sulfate. Clin. Pharmacol. Ther. 1983; 33: 529–536, [PUBMED], [INFOTRIEVE], [CSA]
- Nohmi T., Mizokami K., Kawano S., Fukuhara M., Ishidate M. J. Metabolic activation of phenacetin and phenetidine by several forms of cytochrome P-450 purified from liver microsomes of rats and hamsters. Jpn. J. Cancer Res. 1987; 78: 153–161, [PUBMED], [INFOTRIEVE], [CSA]
- Ouellet M., Percival M. D. Mechanism of acetaminophen inhibition of cyclooxygenase isoforms. Arch. Biochem. Biophys. 2001; 387: 273–280, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Paulus H. E., Whitehouse M. W. Nonsteroid anti-inflammatory agents. Annu. Rev. Pharmacol. 1973; 13: 107–125, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Potter W. Z., Davis D. C., Mitchell J. R., Jollow D. J., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. III. Cytochrome P-450-mediated covalent binding in vitro. J. Pharmacol. Exp. Ther. 1973; 187: 203–210, [PUBMED], [INFOTRIEVE], [CSA]
- Reid A. B., Kurten R. C., McCullough S. S., Brock R. W., Hinson J. A. Mechanisms of acetaminophen-induced hepatotoxicity: role of oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes. J Pharmacol. Exp. Ther. 2005; 312: 509–516, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Roberts D. W., Bucci T. J., Benson R. W., Warbritton A. R., McRae T. A., Pumford N. R., Hinson J. A. Immunohistochemical localization and quantification of the 3-(cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicity. Am. J. Pathol. 1991; 138: 359–371, [PUBMED], [INFOTRIEVE], [CSA]
- Ruepp S. U., Tonge R. P., Shaw J., Wallis N., Pognan F. Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol. Sci. 2002; 65: 135–150, [PUBMED], [INFOTRIEVE], [CSA]
- Rumack B. H. Acetaminophen hepatotoxicity: the first 35 years. J. Toxicol., Clin. Toxicol. 2002; 40: 3–20, [CROSSREF], [CSA]
- Savides M. C., Oehme F. W., Nash S. L., Leipold H. W. The toxicity and biotransformation of single doses of acetaminophen in dogs and cats. Toxicol. Appl. Pharmacol. 1984; 74: 26–34, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Schwab J. M., Beiter T., Linder J. U., Laufer S., Schulz J. E., Meyermann R., Schluesener H. J. FASEB J. 2003; 17: 2174–2175, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sheen C. L., Dillon J. F., Bateman D. N., Simpson K. J., MacDonald T. M. Paracetamol-related deaths in Scotland, 1994–2000. Br. J. Clin. Pharmacol. 2002; 54: 430–432, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Singer A. J., Carracio T. R., Mofenson H. C. The temporal profile of increased transaminase levels in patients with acetaminophen-induced liver dysfunction. Ann. Emerg. Med. 1995; 26: 49–53, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Smilkstein M. J., Bronstein A. C., Linden C., Augenstein W. L., Kulig K. W., Rumack B. H. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann. Emerg. Med. 1991; 20: 1058–1063, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Snyder S. H. Obituary: Julius Axelrod (1912–2004). Nature 2005; 433: 593, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Streeter A. J., Dahlin D. C., Nelson S. D., Baillie T. A. The covalent binding of acetaminophen to protein. Evidence for cysteine residues as major sites of arylation in vitro. Chem. Biol. Interact. 1984; 48: 349–366, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 1971; 231: 232–235, [PUBMED], [INFOTRIEVE], [CSA]
- Vane J. R., Bakhle Y. S., Botting R. M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 1998; 38: 97–120, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Veronese M. E., McLean S., D’Souza C. A., Davies N. W. Formation of reactive metabolites of phenacetin in humans and rats. Xenobiotica 1985; 15: 929–940, [PUBMED], [INFOTRIEVE], [CSA]
- Zaher H., Buters J. T. M., Ward J. M., Bruno M. K., Lucas A. M., Stern S. T., Cohen S. D., Gonzalez F. J. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Toxicol. Appl. Pharmacol. 1998; 152: 193–199, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zhang J., Huang W., Chua S. S., Wei P., Moore D. D. Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science 2002; 298: 422–424, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zhao P., Kalhorn T. F., Slattery J. T. Selective mitochondrial glutathione depletion by ethanol enhances acetaminophen toxicity in rat liver. Hepatology 2002; 36: 326–335, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]